| Medius AG - Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung | | 67463 | | 01 | | Qarziba 20,25 mg/4,5 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01FX06 | | Dinutuximab Beta | | 18.04.2024 | | |
| | Composition | | dinutuximabum beta 20.25 mg, saccharum, histidinum, polysorbatum 20, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 4.5 ml. | | Packungsbestandteile | | Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Dinutuximabum Beta | 20.25mg / 4.5ml |
| | BAG: Active Agent | Dose |
|---|
| Dinutuximabum Beta | 20.25 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum ad Ph | | Histidine | | Polysorbatum 20 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 8084.81 | 8602.80 | A | SL | No |
|
|
